Your browser doesn't support javascript.
loading
A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation.
Toesca, Antonio; Sangalli, Claudia; Maisonneuve, Patrick; Massari, Giulia; Girardi, Antonia; Baker, Jennifer L; Lissidini, Germana; Invento, Alessandra; Farante, Gabriel; Corso, Giovanni; Rietjens, Mario; Peradze, Nickolas; Gottardi, Alessandra; Magnoni, Francesca; Bottiglieri, Luca; Lazzeroni, Matteo; Montagna, Emilia; Labo, Piergiorgio; Orecchia, Roberto; Galimberti, Viviana; Intra, Mattia; Sacchini, Virgilio; Veronesi, Paolo.
Afiliação
  • Toesca A; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Sangalli C; Data Management, European Institute of Oncology IRCCS, Milan, Italy.
  • Maisonneuve P; Division of Epidemiology and Biostatistics, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Massari G; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Girardi A; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Baker JL; Breast Surgery Division, Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA.
  • Lissidini G; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Invento A; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Farante G; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Corso G; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Rietjens M; University of Milan School of Medicine, Milan, Italy.
  • Peradze N; Division of Plastic and Reconstructive Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Gottardi A; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Magnoni F; Division of Plastic and Reconstructive Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Bottiglieri L; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Lazzeroni M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.
  • Montagna E; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Labo P; Division of Medical Senology, European Institute of Oncology IRCCS, Milan, Italy.
  • Orecchia R; Operating Theatre, European Institute of Oncology IRCCS, Milan, Italy.
  • Galimberti V; Scientific Direction, European Institute of Oncology IRCCS, Milan, Italy.
  • Intra M; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Sacchini V; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
  • Veronesi P; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
Ann Surg ; 276(1): 11-19, 2022 07 01.
Article em En | MEDLINE | ID: mdl-34597010
ABSTRACT

OBJECTIVE:

The aim of this study was to compare robotic mastectomy with open classical technique outcomes in breast cancer patients. SUMMARY BACKGROUND DATA As the use of robotic nipple sparing mastectomy continues to rise, improved understanding of the surgical, oncologic, and quality of life outcomes is imperative for appropriate patient selection as well as to better understand indications, limits, advantages, and dangers.

METHODS:

In a phase III, open label, single-center, randomized controlled trial involving 80 women with breast cancer (69) or with BRCA mutation (11), we compared the outcome of robotic and open nipple sparing mastectomy. Primary outcomes were surgical complications and quality of life using specific validated questionnaires. Secondary objective included oncologic outcomes.

RESULTS:

Robotic procedure was 1 hour and 18 minutes longer than open (P < 0.001). No differences in the number or type of complications (P = 0.11) were observed. Breast-Q scores in satisfaction with breasts, psychosocial, physical and sexual well-being were significantly higher after robotic mastectomy versus open procedure. Respect to baseline, physical and sexual well-being domains remained stable after robotic mastectomy, whereas they significantly decreased after open procedure (P < 0.02). The overall Body Image Scale questionnaire score was 20.7 ±â€Š13.8 versus 9.9 ±â€Š5.1 in the robotic versus open groups respectively, P < 0.0001. At median follow-up 28.6months (range 3.7-43.3), no local events were observed.

CONCLUSIONS:

Complications were similar among groups upholding the robotic technique to be safe. Quality of life was maintained after robotic mastectomy while significantly decrease after open surgery. Early follow-up confirm no premature local failure.ClinicalTrials.gov NCT03440398.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia / Procedimentos Cirúrgicos Robóticos Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Ann Surg Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia / Procedimentos Cirúrgicos Robóticos Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Ann Surg Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália